
New ‘Trojan horse’ cancer therapy offers hope for long-term remission
The treatment, now available in England, targets myeloma, a blood cancer affecting plasma cells in the bone marrow. It employs antibodies to deliver chemotherapy directly into cancer cells, functioning like a Trojan horse.